Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
World Drug Safety EUWorld Drug Safety EU
Not Confirmed
Not Confirmed
22-23 September, 2025
Not Confirmed
Not Confirmed
25-26 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
World Drug Safety EUWorld Drug Safety EU
Industry Trade Show
Not Confirmed
22-23 September, 2025
Industry Trade Show
Not Confirmed
25-26 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
31 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/31/2972999/0/en/Lyell-Immunopharma-Completes-Acquisition-of-ImmPACT-Bio.html
24 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/10/24/2969054/0/en/Lyell-Immunopharma-to-Acquire-ImmPACT-Bio-and-Prioritizes-its-Pipeline-to-Focus-on-Next-Generation-CAR-T-cell-Therapies.html
21 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immpact-bio-announces-fda-clearance-of-ind-application-for-cd19cd20-bispecific-car-t-cell-therapy-in-multiple-sclerosis-302226926.html
21 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immpact-bio-to-present-new-preclinical-data-for-cd19cd20-bispecific-car-t-cell-therapy-in-multiple-sclerosis-302150609.html
30 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immpact-bio-to-participate-in-the-2023-truist-securities-biopharma-symposium-301970631.html
15 May 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immpact-bio-granted-fda-fast-track-designation-for-impt-314-in-patients-with-relapsed-or-refractory-aggressive-b-cell-lymphoma-301823604.html
ABOUT THIS PAGE